What next for preimplantation genetic screening? More randomized controlled trials needed? - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Human Reproduction Year : 2008

What next for preimplantation genetic screening? More randomized controlled trials needed?

Abstract

The recent debate on preimplantation genetic screening (PGS) has raised questions about its routine use in clinical practice. It has been suggested that the most effective way to resolve the debate about the usefulness of PGS is to perform more well-designed and well-executed randomized controlled trials (RCTs). However, in view of the lack of evidence for the effectiveness of PGS and the accumulating evidence for its harmfulness, it is our opinion that it is unethical to perform additional RCTs for the indication advanced maternal age using cleavage stage biopsy.

Dates and versions

inserm-00350813 , version 1 (03-02-2009)

Identifiers

Cite

Sebastiaan Mastenbroek, Paul Scriven, Moniek Twisk, Stéphane Viville, Fulco van Der Veen, et al.. What next for preimplantation genetic screening? More randomized controlled trials needed?. Human Reproduction, 2008, 23 (12), pp.2626-8. ⟨10.1093/humrep/den376⟩. ⟨inserm-00350813⟩
41 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More